Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Related Citations for PubMed (Select 20382726)

1.

Therapeutic serum concentrations of daptomycin after intraperitoneal administration in a patient with peritoneal dialysis-associated peritonitis.

Bahte SK, Bertram A, Burkhardt O, Martens-Lobenhoffer J, Goedecke V, Bode-Böger SM, Hiss M, Kielstein JT.

J Antimicrob Chemother. 2010 Jun;65(6):1312-4. doi: 10.1093/jac/dkq118. Epub 2010 Apr 9. No abstract available.

2.

Intraperitoneal daptomycin.

García-López L, Gómez Sayago L, Fernández-Reyes Luis MJ.

Nefrologia. 2011;31(3):375-6. doi: 10.3265/Nefrologia.pre2011.Mar.10806. English, Spanish. No abstract available.

3.

Treatment of enterococcal peritonitis with intraperitoneal daptomycin in a vancomycin-allergic patient and a review of the literature.

Gilmore JF, Kim M, LaSalvia MT, Mahoney MV.

Perit Dial Int. 2013 Jul-Aug;33(4):353-7. doi: 10.3747/pdi.2012.00277. Review.

5.
6.

Intraperitoneal compared with intravenous meropenem for peritoneal dialysis-related peritonitis.

Vlaar PJ, van Hulst M, Benne CA, Janssen WM.

Perit Dial Int. 2013 Nov-Dec;33(6):708-9. doi: 10.3747/pdi.2012.00155. No abstract available.

7.

Treatment with intravenous daptomycin for a peritonitis relapse caused by Staphylococcus epidermidis.

Levy F, Camarero Temiño V, Blasco Mollá A, Ortega Lafont MP, Abaigar Luquin P, Izquierdo Ortiz MJ, Torres Torres G.

Nefrologia. 2011;31(3):374-5. doi: 10.3265/Nefrologia.pre2011.Mar.10810. English, Spanish. No abstract available.

8.

Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.

Huen SC, Hall I, Topal J, Mahnensmith RL, Brewster UC, Abu-Alfa AK.

Am J Kidney Dis. 2009 Sep;54(3):538-41. doi: 10.1053/j.ajkd.2008.12.017. Epub 2009 Feb 23.

PMID:
19237231
9.

Plasma and peritoneal dialysate levels during daptomycin therapy for peritonitis.

Khadzhynov D, Joukhadar C, Peters H.

Am J Kidney Dis. 2009 May;53(5):911-2. doi: 10.1053/j.ajkd.2009.02.017. No abstract available.

PMID:
19393474
10.

Intraperitoneal administration of daptomycin in recurrent peritonitis with suspected biofilm.

García-López L, Fernández-Reyes Luis MJ, Criado-Illana MT, Gómez-Sayago L, Heras-Benito M.

Nefrologia. 2012;32(2):139-42. doi: 10.3265/Nefrologia.pre2011.Nov.11066. Epub 2012 Feb 4. English, Spanish.

11.

Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).

Varghese JM, Roberts JA, Wallis SC, Boots RJ, Healy H, Fassett RG, Lipman J, Ranganathan D.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1249-56. doi: 10.2215/CJN.12211211. Epub 2012 Jun 14.

12.

Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.

Benziger DP, Pertel PE, Donovan J, Yankelev S, Schwab RJ, Swan SK, Cannon C.

Clin Nephrol. 2011 Jan;75(1):63-9.

PMID:
21176752
13.

Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics.

Diaz-Buxo JA, Crawford TL, Bailie GR.

Perit Dial Int. 2001;21 Suppl 3:S197-201. No abstract available.

14.

Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient.

Goedecke VA, Clajus C, Burkhardt O, Martens-Lobenhoffer J, Bode-Boger SM, Kielstein JT, Hiss M.

Scand J Infect Dis. 2009;41(2):155-7. doi: 10.1080/00365540802613095.

PMID:
19085620
15.

Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen.

Fielding RE, Clemenger M, Goldberg L, Brown EA.

Perit Dial Int. 2002 May-Jun;22(3):345-9.

16.

Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis.

Burkhardt O, Joukhadar C, Traunmüller F, Hadem J, Welte T, Kielstein JT.

J Antimicrob Chemother. 2008 Jan;61(1):224-5. Epub 2007 Oct 26. No abstract available.

17.

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study.

Ranganathan D, Varghese JM, Fassett RG, Lipman J, D'Intini V, Healy H, Roberts JA.

BMC Nephrol. 2009 Dec 16;10:42. doi: 10.1186/1471-2369-10-42.

19.
20.

Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.

Sisterhen LL, Stowe CD, Farrar HC, Blaszak CK, Blaszak RT.

Am J Kidney Dis. 2006 Mar;47(3):503-8.

PMID:
16490630
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk